SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001457612-22-000054
Filing Date
2022-05-05
Accepted
2022-05-05 16:10:20
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gnca-20220331.htm   iXBRL 10-Q 918905
2 EX-31.1 a2022q1ex311.htm EX-31.1 11821
3 EX-31.2 a2022q1ex312.htm EX-31.2 11463
4 EX-32 a2022q1ex32.htm EX-32 9267
10 gnca-20220331_g1.jpg GRAPHIC 16581
11 gnca-20220331_g2.jpg GRAPHIC 183524
12 gnca-20220331_g3.jpg GRAPHIC 107733
  Complete submission text file 0001457612-22-000054.txt   6022956

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnca-20220331.xsd EX-101.SCH 37707
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gnca-20220331_cal.xml EX-101.CAL 45048
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gnca-20220331_def.xml EX-101.DEF 226655
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnca-20220331_lab.xml EX-101.LAB 507047
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnca-20220331_pre.xml EX-101.PRE 360097
63 EXTRACTED XBRL INSTANCE DOCUMENT gnca-20220331_htm.xml XML 766207
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36289 | Film No.: 22896315
SIC: 2836 Biological Products, (No Diagnostic Substances)